038.F
NovoCure Limited
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
14.42
▼ 0.49 (3.29%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
14.42
Prev close
14.91
Day high
14.42
Day low
14.42
Volume
30
Market cap
$1.68B
P/E (TTM)
—
52W range
8.12 – 17.24
Day trading desk
Gap from prior close
-4.98%
Prior close 15.18
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
—
14.42 – 14.42
Position in range
—
—
ATR (14D)
0.51
3.57% of price
Prior day high
15.18
PDH
Prior day low
15.18
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 81
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.98%
+2.2%
1M
-12.29%
-15.6%
3M
-3.06%
-5.4%
6M
+58.11%
+46.2%
YTD
+36.04%
+24.1%
1Y
+56.32%
+36.2%
3Y
-11.98%
-87.0%
5Y
-86.68%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 038.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
11.60M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 30, 26 | BEN ARYE BARAK General Counsel |
STOCK | 1.30K | $19.68K | Direct |
| Jun 30, 26 | PURI MICHAL NATH Officer |
STOCK | 1.91K | $28.86K | Direct |
| Jun 30, 26 | DANZIGER ASAF Director |
STOCK | 268 | $4.06K | Direct |
| Jun 30, 26 | LEONARD FRANCIS XAVIER II Chief Executive Officer |
STOCK | 1.91K | $28.86K | Direct |
| Jun 4, 26 | LEONARD FRANCIS XAVIER II Chief Executive Officer |
SELL | 34.27K | $614.63K | Direct |
| Jun 3, 26 | OCEAN ALLYSON J Director |
STOCK | 11.61K | $0 | Direct |
| Jun 3, 26 | STAFFORD KRISTIN Director |
STOCK | 11.61K | $0 | Direct |
| Jun 3, 26 | MADDEN MARTIN J Director |
STOCK | 11.61K | $0 | Direct |
| Jun 3, 26 | HILLEMAN JERYL L Director |
STOCK | 11.61K | $0 | Direct |
| Jun 3, 26 | LEUNG KINYIP GABRIEL Director |
STOCK | 11.61K | $0 | Direct |
| Jun 3, 26 | HUNG DAVID T Director |
STOCK | 11.61K | $0 | Direct |
| Jun 3, 26 | VERNON WILLIAM ANTHONY Director |
STOCK | 11.61K | $0 | Direct |
| Jun 3, 26 | SCANNELL TIMOTHY J. Director |
STOCK | 11.61K | $0 | Direct |
| Jun 2, 26 | OCEAN ALLYSON J Director |
SELL | 2.94K | $46.45K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BEN ARYE BARAK |
General Counsel | 243.75K | Stock Award(Grant) |
BRACKMANN CHRISTOPH |
Chief Financial Officer | 182.84K | Sale |
CORDOVA ASHLEY |
Former | 440.21K | Stock Award(Grant) |
DANZIGER ASAF |
Director | 416.74K | Stock Award(Grant) |
DOYLE WILLIAM F |
Officer and Director | 328.40K | Stock Award(Grant) |
LEONARD FRANCIS XAVIER II |
Chief Executive Officer | 461.43K | Stock Award(Grant) |
LEUPIN NICOLAS |
Former | 102.98K | Sale |
PURI MICHAL NATH |
Officer | 203.23K | Stock Award(Grant) |
VERNON WILLIAM ANTHONY |
Director | 209.27K | Stock Award(Grant) |
WEINBERG URI |
Officer | 267.19K | Sale |
Fundamentals
Market cap$1.68B
Enterprise value$1.47B
Revenue (TTM)$699.19M
Gross profit$533.98M
EBITDA$-136.39M
Net income$-148.56M
EPS (TTM)$-1.11
Free cash flow$22.76M
Total cash$440.56M
Total debt$233.42M
Book value / share$2.49
Shares outstanding116.45M
Float96.42M
Short % of float—
Dividend yield—
Beta (5Y)0.98
Valuation & profitability ratios
Trailing P/E—
Forward P/E-721.00
PEG ratio—
Price / sales—
Price / book5.80
EV / revenue2.11
EV / EBITDA-10.79
Gross margin76.37%
Operating margin-5.75%
Profit margin-21.25%
Return on equity-43.22%
Return on assets-9.26%
Debt / equity69.04
Current ratio2.89
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $655.35M | $605.22M | $509.34M | $537.84M | +8.3% |
| Operating revenue | $655.35M | $605.22M | $509.34M | $537.84M | +8.3% |
| Cost of revenue | $166.88M | $137.18M | $128.28M | $114.87M | +21.6% |
| Gross profit | $488.47M | $468.04M | $381.06M | $422.97M | +4.4% |
| Research & development | $224.54M | $209.65M | $223.06M | $206.09M | +7.1% |
| Selling, general & admin | $417.73M | $428.89M | $390.87M | $306.41M | -2.6% |
| Total operating expense | $642.27M | $638.53M | $613.93M | $512.50M | +0.6% |
| Operating income | -$153.80M | -$170.50M | -$232.87M | -$89.52M | +9.8% |
| Net interest income | $21.87M | $40.05M | $41.93M | $11.20M | -45.4% |
| Pre-tax income | -$136.25M | -$131.16M | -$191.74M | -$81.85M | -3.9% |
| Tax provision | -$23.00K | $37.47M | $15.30M | $10.69M | -100.1% |
| Net income | -$136.23M | -$168.63M | -$207.04M | -$92.53M | +19.2% |
| Net income to common | -$136.23M | -$168.63M | -$207.04M | -$92.53M | +19.2% |
| Basic EPS | -1.22 | -1.56 | -1.95 | -0.88 | +21.8% |
| Diluted EPS | -1.22 | -1.56 | -1.95 | -0.88 | +21.8% |
| EBIT | -$119.21M | -$120.82M | -$188.42M | -$78.51M | +1.3% |
| EBITDA | -$104.56M | -$109.58M | -$177.45M | -$67.89M | +4.6% |
| Basic shares | 111.47M | 107.83M | 106.39M | 104.66M | +3.4% |
| Diluted shares | 111.47M | 107.83M | 106.39M | 104.66M | +3.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $93.55M | $163.77M | $240.82M | $115.33M | -42.9% |
| Cash & short-term investments | $447.67M | $959.87M | $910.62M | $969.42M | -53.4% |
| Accounts receivable | $89.44M | $74.23M | $61.22M | $86.26M | +20.5% |
| Inventory | $41.11M | $35.09M | $38.15M | $29.38M | +17.2% |
| Total current assets | $646.73M | $1.11B | $1.03B | $1.11B | -41.6% |
| Property, plant & equipment | $147.00M | $119.59M | $97.70M | $68.96M | +22.9% |
| Total assets | $804.33M | $1.24B | $1.15B | $1.19B | -35.2% |
| Total current liabilities | $223.23M | $756.39M | $179.12M | $158.78M | -70.5% |
| Current debt | — | $558.16M | — | — | — |
| Long-term debt | $195.05M | $97.30M | $568.82M | $565.51M | +100.5% |
| Total debt | $248.35M | $683.34M | $604.56M | $584.27M | -63.7% |
| Total liabilities | $463.86M | $880.61M | $783.63M | $750.48M | -47.3% |
| Retained earnings | -$1.29B | -$1.15B | -$985.50M | -$778.46M | -11.8% |
| Shareholder equity | $340.47M | $360.18M | $362.50M | $441.17M | -5.5% |
| Working capital | $423.50M | $350.18M | $855.29M | $952.75M | +20.9% |
| Net tangible assets | $340.47M | $360.18M | $362.50M | $441.17M | -5.5% |
| Shares issued | 112.49M | 108.52M | 107.08M | 105.05M | +3.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$136.23M | -$168.63M | -$207.04M | -$92.53M | +19.2% |
| Depreciation & amortisation | $14.65M | $11.23M | $10.97M | $10.62M | +30.4% |
| Stock-based compensation | $104.83M | $160.03M | $115.61M | $106.95M | -34.5% |
| Change in working capital | -$20.07M | -$3.65M | $29.66M | $11.80M | -450.2% |
| Operating cash flow | -$49.03M | -$26.37M | -$73.34M | $30.79M | -85.9% |
| Capital expenditure | -$26.65M | -$42.85M | -$27.09M | -$21.36M | +37.8% |
| Investing cash flow | $437.28M | -$140.24M | $184.15M | -$139.96M | +411.8% |
| Financing cash flow | -$451.34M | $90.31M | $15.79M | $15.49M | -599.7% |
| Free cash flow | -$75.68M | -$69.22M | -$100.43M | $9.43M | -9.3% |
| End cash position | $103.39M | $166.09M | $242.56M | $115.83M | -37.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $183.58M | $174.06M | $174.35M | $167.20M | $158.81M | — | +5.5% |
| Operating revenue | $183.58M | $174.06M | $174.35M | $167.20M | $158.81M | — | +5.5% |
| Cost of revenue | $41.11M | $38.93M | $42.16M | $44.73M | $41.47M | — | +5.6% |
| Gross profit | $142.48M | $135.13M | $132.19M | $122.47M | $117.33M | — | +5.4% |
| Research & development | $51.45M | $58.34M | $60.91M | $54.03M | $55.83M | — | -11.8% |
| Selling, general & admin | $101.59M | $144.21M | $111.68M | $104.47M | $101.02M | — | -29.6% |
| Total operating expense | $153.04M | $202.55M | $172.59M | $158.50M | $156.85M | — | -24.4% |
| Operating income | -$10.56M | -$67.42M | -$40.39M | -$36.02M | -$39.52M | — | +84.3% |
| Net interest income | -$1.89M | -$1.84M | $3.76M | $6.00M | $4.54M | — | -2.8% |
| Pre-tax income | -$12.45M | -$69.26M | -$40.95M | -$30.02M | -$34.98M | — | +82.0% |
| Tax provision | $3.21M | $1.88M | -$16.45M | $7.25M | $5.16M | — | +70.5% |
| Net income | -$15.66M | -$71.14M | -$24.50M | -$37.27M | -$40.14M | — | +78.0% |
| Net income to common | -$15.66M | -$71.14M | -$24.50M | -$37.27M | -$40.14M | — | +78.0% |
| Basic EPS | -0.13 | -0.62 | -0.22 | — | -0.36 | -0.31 | +79.0% |
| Diluted EPS | -0.13 | -0.62 | -0.22 | — | -0.36 | -0.31 | +79.0% |
| EBIT | -$10.56M | -$67.42M | -$5.81M | -$36.02M | -$39.52M | — | +84.3% |
| EBITDA | -$6.25M | -$63.30M | -$1.59M | -$32.36M | -$36.08M | — | +90.1% |
| Basic shares | 116.01M | 114.15M | 112.24M | — | 111.57M | 110.28M | +1.6% |
| Diluted shares | 116.01M | 114.15M | 112.24M | — | 111.57M | 110.28M | +1.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $93.70M | $87.53M | $93.55M | $342.12M | $149.62M | — | +7.1% |
| Cash & short-term investments | $440.56M | $432.00M | $447.67M | $1.03B | $911.52M | — | +2.0% |
| Accounts receivable | $91.46M | $93.27M | $89.44M | $85.23M | $82.97M | — | -1.9% |
| Inventory | $42.22M | $43.46M | $41.11M | $39.10M | $40.21M | — | -2.8% |
| Total current assets | $638.52M | $631.66M | $646.73M | $1.20B | $1.08B | — | +1.1% |
| Property, plant & equipment | $145.74M | $145.06M | $147.00M | $148.93M | $147.01M | — | +0.5% |
| Total assets | $795.19M | $787.93M | $804.33M | $1.36B | $1.25B | — | +0.9% |
| Total current liabilities | $220.71M | $217.58M | $223.23M | $776.01M | $749.63M | — | +1.4% |
| Current debt | — | — | — | $560.62M | $559.79M | $558.97M | — |
| Long-term debt | $195.89M | $195.46M | $195.05M | $194.64M | $97.61M | — | +0.2% |
| Total debt | $233.42M | $234.94M | $248.35M | $797.94M | $700.25M | — | -0.6% |
| Total liabilities | $457.10M | $457.21M | $463.86M | $1.02B | $896.43M | — | -0.0% |
| Retained earnings | -$1.38B | -$1.36B | -$1.29B | -$1.27B | -$1.23B | — | -1.2% |
| Shareholder equity | $338.09M | $330.72M | $340.47M | $341.33M | $349.44M | — | +2.2% |
| Working capital | $417.81M | $414.08M | $423.50M | $423.85M | $333.67M | — | +0.9% |
| Net tangible assets | $338.09M | $330.72M | $340.47M | $341.33M | $349.44M | — | +2.2% |
| Shares issued | 116.44M | 115.82M | 112.49M | 111.98M | 111.80M | — | +0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$15.66M | -$71.14M | -$24.50M | -$37.27M | -$40.14M | +78.0% |
| Depreciation & amortisation | $4.31M | $4.12M | $4.22M | $3.66M | $3.44M | +4.4% |
| Stock-based compensation | $17.01M | $63.01M | $19.82M | $29.32M | $26.14M | -73.0% |
| Change in working capital | $4.21M | -$7.87M | -$15.28M | $29.35M | -$6.64M | +153.5% |
| Operating cash flow | $8.13M | -$13.52M | -$18.00M | $20.57M | -$15.94M | +160.2% |
| Capital expenditure | -$6.92M | -$5.15M | -$4.90M | -$5.66M | -$5.49M | -34.2% |
| Investing cash flow | -$6.38M | $7.75M | $336.33M | $71.44M | $35.99M | -182.3% |
| Financing cash flow | $4.55M | -$166.00K | -$559.49M | $100.52M | $2.39M | +2,839.8% |
| Free cash flow | $1.22M | -$18.67M | -$22.90M | $14.92M | -$21.42M | +106.5% |
| End cash position | $103.62M | $97.32M | $103.39M | $344.64M | $152.13M | +6.5% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $182.23M | +9.0% |
| Next quarter | — | — | $185.78M | +6.6% |
| Current year | — | — | $725.84M | +10.8% |
| Next year | — | — | $804.78M | +10.9% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders9.96%
Held by institutions90.69%
Institutions holding312
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
14.72
-2.03% from price
SMA 20
14.21
+4.89% from price
SMA 50
14.01
+6.43% from price
SMA 100
13.35
+7.99% from price
SMA 200
11.89
+25.45% from price
EMA 12
14.60
-1.23% from price
EMA 26
14.37
+0.38% from price
EMA 50
14.09
+2.36% from price
RSI (14)
54.2
Neutral
MACD (12,26,9)
0.23
Hist 0.09
ATR (14)
0.51
3.45% of price
Realised vol 30D
90.5%
Annualised
Bollinger upper
15.88
20, 2σ
Bollinger lower
12.55
20, 2σ
50 / 200 cross
Golden
14.01 vs 11.89
Trend bias
Above 200
+25.45%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.74
Less volatile than market
Correlation to SPY
0.11
Largely independent
Realised vol 30D
90.5%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-35.2%
Peak to trough
Max drawdown 5Y
-93.1%
Peak to trough
ATR 14
0.51
3.45% of price
Beta (reported)
0.98
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 24, 26 | Wedbush | MAINTAINED | Neutral | Neutral |
| Jul 23, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 18, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 4, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| May 1, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Apr 16, 26 | Wedbush | MAINTAINED | Neutral | Neutral |
| Feb 26, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Feb 12, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jan 15, 26 | Wedbush | MAINTAINED | Neutral | Neutral |
| Jan 13, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Oct 30, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Oct 27, 25 | JP Morgan | MAINTAINED | Neutral | Neutral |
Headlines
Why IMAX Stock Climbed to a New All-Time High Today
Motley Fool · 10m ago
Shell’s Chemicals Exit Attracts XOM and LYB: Capital Discipline or Missed Opportunity?
Insider Monkey · 10m ago
Tesla (TSLA)’s Solar Roof Shutdown Raises Questions About its Energy Ambitions
Insider Monkey · 14m ago
UPS Builds for Future Growth With $2 Billion Global Logistics Investment
Insider Monkey · 15m ago
Aramco Signs $3.7 Billion in Deals With French Companies
Oilprice.com · 15m ago
Altria vs. Philip Morris: What the New Manufacturing Deal Means for Investors
Insider Monkey · 17m ago
Dollar struggles for traction as markets weigh Iran sanctions, Treasury buybacks
Reuters · 17m ago
Can Walmart’s (WMT) New Scenario Brand Drive Its Next Phase of Growth?
Insider Monkey · 18m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.